BC-3781: Clinical Trials

1 trial of BC-3781, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow BC-3781: new trials by email Literature Review of BC-3781 trials Research Report on BC-3781

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study Comparing the Safety and Efficacy of Two Doses of BC-3781 vs Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
BC-3781, Vancomycin - Bacterial Infections, Infection
Phase 2CompletedNabriva Therapeutics AG2102010-05-012020-11-17

Conditions studied

Bacterial Infections (1)  ·  Infections (1)

Sponsors

Nabriva Therapeutics AG (1)

Countries

United States (1)

Top investigators

William T. Prince, Dr. (1)

Results publications

PMID 25348519